HomeNewsWorld NewsAfter Illumina CEO’s Fall, Other Executives May Take Hard Look Before Deal Making

After Illumina CEO’s Fall, Other Executives May Take Hard Look Before Deal Making

Francis deSouza resigned from gene-sequencing maker after regulators challenged $7.1 billion deal, triggering proxy battle with Carl Icahn.

Leave a Reply

Your email address will not be published. Required fields are marked *

Disclaimer:

Copyright: © 2023 iSeekFX. All Rights Reserved.